Pictet Asset Management Holding SA Acquires 10,866 Shares of Aehr Test Systems $AEHR

Pictet Asset Management Holding SA lifted its holdings in shares of Aehr Test Systems (NASDAQ:AEHR) by 187.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,654 shares of the semiconductor company’s stock after purchasing an additional 10,866 shares during the period. Pictet Asset Management Holding SA owned 0.05% of Aehr Test Systems worth $1,600,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP increased its holdings in Aehr Test Systems by 129.9% in the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock valued at $16,771,000 after purchasing an additional 469,400 shares during the period. Invesco Ltd. raised its position in Aehr Test Systems by 1,137.2% during the 3rd quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock worth $11,037,000 after purchasing an additional 336,940 shares during the last quarter. Next Century Growth Investors LLC lifted its holdings in Aehr Test Systems by 99.9% during the 4th quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock worth $11,155,000 after buying an additional 276,160 shares during the period. Halter Ferguson Financial Inc. lifted its holdings in Aehr Test Systems by 41.7% during the 4th quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock worth $12,965,000 after buying an additional 189,117 shares during the period. Finally, Squarepoint Ops LLC lifted its holdings in Aehr Test Systems by 1,321.9% during the 4th quarter. Squarepoint Ops LLC now owns 100,199 shares of the semiconductor company’s stock worth $2,023,000 after buying an additional 108,399 shares during the period. Institutional investors own 69.69% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on AEHR shares. Craig Hallum reissued a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Lake Street Capital reaffirmed a “buy” rating and issued a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Weiss Ratings cut Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Finally, Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $136.67.

Insider Activity

In related news, EVP Alberto Salamone sold 9,672 shares of the company’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the sale, the executive vice president owned 41,962 shares in the company, valued at $5,359,386.64. This represents a 18.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard T. Slayen sold 5,700 shares of the company’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $133.03, for a total value of $758,271.00. Following the sale, the director owned 140,667 shares in the company, valued at approximately $18,712,931.01. The trade was a 3.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 109,475 shares of company stock worth $13,827,160. 6.80% of the stock is owned by insiders.

Aehr Test Systems News Summary

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Stock Up 8.7%

AEHR stock opened at $134.06 on Friday. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a 12-month low of $16.38 and a 12-month high of $147.40. The company’s fifty day simple moving average is $92.83 and its 200 day simple moving average is $71.45.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.